2BB score and signals
Coya Therapeutics, Inc.’s current 2BB score is 27 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 10 | Very Low |
| Momentum | 42 | Stable |
| Financial strength | 34 | Weak |
| Quality | 20 | Weak |
| Risk | 46 | Moderate |
Company facts
| Headquarters | Houston, Texas, United States |
| Founded | 2020 |
| Employees | 8 |
| 52-week range | $3.71 – $7.75 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-10 | — | -0.3526 | — | $87,424.00 |
| 2026-08-18 | — | -0.3468 | — | $102,000.00 |
| 2026-05-12 | -0.32 | -0.4216 | $251,000.00 | $127,500.00 |
| 2026-03-16 | -0.34 | -0.2783 | $3.96M | $1.97M |
Related companies
